Bioequivalence Study of Donepezil Hydrochloride Tablets in Healthy Male Volunteers
Open Access
- 1 November 2012
- journal article
- Published by Wiley in ISRN Pharmacology
- Vol. 2012, 1-4
Abstract
The objective of this study was to investigate the bioequivalence of two formulations of 5 mg donepezil HCL tablets: Tonizep as the test and Aricept as the reference. The two products were administered as a single oral dose according to a randomized two-phase crossover with a 3-week washout period in 20 healthy Thai Male volunteers. After drug administration, serial blood samples were collected over a period of 216 hours. Plasma donepezil concentrations were measured by high performance liquid chromatography with UV detection. Pharmacokinetic parameters were analyzed based on noncompartmental analysis. The logarithmically transformed data of AUC0–∞ and were analyzed for 90% confidence intervals (CI) using ANOVA. The mean (90% CI) values for the ratio of AUC0–∞ and values of the test product over those of the reference product were 1.08 (1.02–1.14) and 1.08 (0.99–1.17), respectively (within the bioequivalence range of 0.8–1.25). The median for the test product was similar to that of the reference product (2.0 hr), and the 90% CI for the difference between the two preparations was –0.19 to 0.29 hr and within the bioequivalence range of ± 20% of the of the reference formulation. Our study demonstrated the bioequivalence of the two preparations.Keywords
This publication has 11 references indexed in Scilit:
- The safety and tolerability of donepezil in patients with Alzheimer's diseaseBritish Journal of Clinical Pharmacology, 2004
- Determination of Donepezil Hydrochloride (E2020) in Plasma by Liquid Chromatography--Mass Spectrometry and Its Application to Pharmacokinetic Studies in Healthy, Young, Chinese SubjectsJournal of Chromatographic Science, 2004
- [Bioequivalence of donepezil capsule and tablet in human].2003
- Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral dosesBritish Journal of Clinical Pharmacology, 1998
- An evaluation of the pharmacokinetics of donepezil HCl in patients with moderately to severely impaired renal functionBritish Journal of Clinical Pharmacology, 1998
- Sorivudine and 5‐fluorouracil; a clinically significant drug‐drug interaction due to inhibition of dihydropyrimidine dehydrogenaseBritish Journal of Clinical Pharmacology, 1998
- Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension studyEuropean Neuropsychopharmacology, 1998
- Bioequivalence requirements for generic productsPharmacology & Therapeutics, 1994
- Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly SubjectsThe Journal of Clinical Pharmacology, 1993
- Presentation of results from bioequivalence studies.1992